![](/uploadedImages/Bio-IT_World/Whitepaper_SmartForms/Mech_NovellaClin-logo.jpg?n=8176)
Optimizing Early Phase Oncology Clinical Trials
Oncology products continue to dominate the global therapeutics market. With anticipated continued strength, this therapeutic area will reach approximately $75 billion in global spending by 2015. Further, anticancer drugs continue to be the leading research therapeutic, with 672 oncology drugs in development.